1.43  -0.043 (-2.89%)		10-24 13:56
Open: 1.48 High: 1.48 Volume: 12,500		Pre. Close: 1.4725 Low: 1.42 Market Cap: 25(M)

Short term
Mid term
Targets	6-month :	2.07	1-year :	2.42
Resists	First :	1.77	Second :	2.07
Pivot price	1.44
Supports	First :	1.31	Second :	1.01
MAs	MA(5) :	1.45	MA(20) :	1.43
	MA(100) :	1.34	MA(250) :	1.17
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	51.2	D(3) :	54
RSI	RSI(14): 52
52-week	High :	1.77	Low :	0.47

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MRAI ] has closed above bottom band by 45.1%. Bollinger Bands are 34.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1.5 - 1.51	1.51 - 1.52
Low:	1.37 - 1.38	1.38 - 1.39
Close:	1.38 - 1.39	1.39 - 1.4

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.

Fri, 17 Oct 2025
Marpai (MRAI) 10% owners sell $270,640 in shares - Investing.com

Tue, 14 Oct 2025
Top Health Plan TPA 2025 — Marpai recognized for tech-driven approach in $150B TPA sector - Stock Titan

Mon, 06 Oct 2025
Marpai Receives Additional $200,000 Investment From Damien Lamendola's Hillcour Investment Fund - TradingView

Mon, 06 Oct 2025
$200K Investment — Marpai Secures Private Placement from CEO‑Controlled HillCour; Q3 Total $1.7M - Stock Titan

Mon, 06 Oct 2025
MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND - PR Newswire

Tue, 16 Sep 2025
Marpai announces pricing of $700,000 private placement - MSN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: OTC
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	14 (M)
Shares Float	2 (M)
Held by Insiders	70.6 (%)
Held by Institutions	0 (%)
Shares Short	12 (K)
Shares Short P.Month	117 (K)

EPS	-2.93
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-2.33
Profit Margin	-92.8 %
Operating Margin	-65.2 %
Return on Assets (ttm)	-37.3 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	-28.4 %
Gross Profit (p.s.)	0
Sales Per Share	2.32
EBITDA (p.s.)	-1.34
Qtrly Earnings Growth	0 %
Operating Cash Flow	-14 (M)
Levered Free Cash Flow	-9 (M)

PE Ratio	-0.49
PEG Ratio	0
Price to Book value	-0.62
Price to Sales	0.61
Price to Cash Flow	-1.44

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.